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Abstract.  The expression of receptors and the mito- 
genic response to PDGF by C2 myoblasts, derived 
from adult mouse skeletal muscle, was investigated. 
Employing *25I-PDGF binding assays, we showed that 
the cells exhibit high level binding of PDGF-BB 
(,,o165  ×  103 molecules/cell at saturation) and much 
lower binding of the PDGF-AA and PDGF-AB (6-12 
)<  l03 molecules/cell at saturation).  This indicates that 
the C2 myoblasts express high levels of PDGF recep- 
tor 3-subunits and low levels of ~-subunits.  PDGF-BB 
enhances the proliferation of C2 cells maintained in 
2%  FCS by about fivefold. PDGF-AB had a  moderate 
effect on cell proliferation (less than twofold) and 
PDGF-AA had no effect. Inverse effects of PDGF iso- 
forms on the frequency of differentiated myoblasts 
were observed; the frequency of myosin-positive cells 
was reduced in the presence of PDGF-BB while 
PDGF-AA and PDGF-AB had no effect. PDGF may 
thus act to increase the number of myoblasts that par- 
ticipate in muscle regeneration following muscle 
trauma by stimulating the proliferation and by inhibit- 
ing the differentiation of myogenic cells. 
T 
HROUGHOUT embryogenesis of skeletal muscle, myo- 
genic precursors proliferate and eventually give rise to 
terminally differentiated,  fusion-capable  myoblasts. 
During postnatal growth, the myogenic precursor cells are 
still in their proliferative phase (Moss and Leblond, 1971) 
but in adult muscle,  these cells are  mitotically quiescent 
(Schultz et al.,  1978).  The myogenic precursor cells in the 
adult,  which  are  often referred  to  as  satellite cells,  can 
reinitiate proliferative activity after muscle injury, and their 
progeny fuse into multinucleated fibers (Snow, 1977; Mauro, 
1979; reviewed in Campion, 1984). Adult satellite cells also 
become mitotically active upon culturing, displaying a pro- 
gram of proliferation and differentiation similar to that of 
embryonic myoblasts (Bischoff, 1974;  Yablonka-Reuveni  et 
al.,  1987).  Studies on adult-derived myoblasts have iden- 
tified several physiological growth factors that could regulate 
the quiescent and proliferative states of satellite cells. These 
factors include FGF, insulin-like growth factors, and trans- 
forming growth factor 3 (Allen et al., 1984; Allen and Box- 
horn, 1989; Bischoff, 1986; Clegg et al., 1987; Jennische et 
al., 1987; DiMario and Strohman, 1988; reviewed in Florini 
and Magri,  1989). 
PDGF has been implicated as an important mediator of 
wound healing and tissue repair (reviewed in Ross et al., 
1986),  but its role during skeletal muscle regeneration has 
not been fully investigated. PDGF is a potent mitogen for 
many mesenchymal cells including fibroblasts and smooth 
muscle cells  (reviewed in Ross  et al.,  1986;  Heldin and 
Westermark,  1989) and was recently also shown to play a 
role in the proliferation and differentiation of specific cells 
in the glial cell lineage (Hart et al., 1989; reviewed in Heldin 
and Westermark, 1989). PDGF can also elicit other biologi- 
cal  responses,  including  increased  metabolic  rates  and 
chemotaxis  (reviewed  in  Ross  et  al.,  1986;  Heldin  and 
Westermark, 1989). Two homodimeric forms ofPDGF (AA 
and BB) and one heterodimeric form (AB) have been purified 
from mammals and are functionally active (Bowen-Pope  et 
al., 1989). Although PDGF was initially isolated from plate- 
lets and megakaryocytes, it is now well established that other 
cell types are also capable of producing this growth factor 
(reviewed in Ross et al.,  1986;  Heldin and Westermark, 
1989).  There are at least two separate PDGF receptor pro- 
teins which differ in their specificities for the two chains of 
PDGF (Hart et al.,  1988;  Heldin et al.,  1988).  According 
to the model proposed by Seifert et al. (1989), the two differ- 
ent receptor proteins function as subunits (designated o~ and 
t) which dimerize to form three distinct receptors (c~u, u3, 
33) (Seifert et al.,  1989;  Heldin et al.,  1989;  Hammacher 
et al.,  1989).  PDGF-AA can only bind to the cct~ receptor, 
PDGF-AB can bind to both c~a and o~3 receptor, and PDGF- 
BB can bind to all three receptor subunit combinations: t~c~, 
a3, and 33. 
In this study, we analyzed the effect of the three PDGF 
dimers on the myogenic cell line C2, which was derived from 
normal adult mouse muscle (Yaffe and Saxel,  1977) and is 
presumably derived from satellite cells. We chose to study 
a cell line rather than primary cells in order to avoid the com- 
plexity introduced by fibroblast-like cells which are present 
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(Yablonka-Reuveni et al.,  1988,  1990; manuscript in prepa- 
ration). We used the C2 cell line because it has been demon- 
strated to be able to participate in muscle regeneration in 
vivo (Partridge et al., 1988). Nevertheless, we recognize that 
the behavior of the C2 cells in vitro may not completely re- 
produce the behavior of the satellite cells in vivo. 
We were able to demonstrate significant binding of all 
three PDGF dimers, with a much higher number of PDGF- 
BB molecules bound at saturation compared to PDGF-AA 
and PDGF-AB. PDGF-BB also significantly promoted cell 
proliferation and depressed the frequency of differentiated 
myoblasts. PDGF-AB had only a small effect on cell prolifer- 
ation,  and no effects of PDGF-AA could be documented. 
PDGF-BB may thus play a role during muscle regeneration 
by increasing the number of  proliferating myoblasts available 
for repair following muscle trauma. 
Materials and Methods 
Cell Culture 
C2 cells, originally isolated from adult mouse skeletal muscle (Yaffe and 
Saxel,  1977),  were kindly provided by D. Yaffe (The Weizmann Institute 
of Science, Rehovot, Israel).  Cells were maintained at 37.5°C in water- 
saturated air containing 5 % CO2, using gelatin-coated, 100-mm tissue cul- 
ture dishes. Proliferation medium consisted of MEM (Gibco Laboratories, 
Grand Island, NY) containing 20% FCS (HyClone Laboratories, Logan, 
UT), 0.5 % chicken embryo extract, penicillin, and streptomycin at 105 U 
per liter each.  It should be noted that the cells can differentiate in this 
medium when they reach very high cell density. For subculturing, sparse 
cells were exposed to 1.25 % trypsin (Gibco Laboratories) for "~30 min at 
37°C. Cells were then mechanically triturated, filtered through lens paper 
to  eliminate  cell  aggregates  (Yablonka-Reuveni  and  Nameroff,  1987), 
counted in a hemocytometer, and further cultured as described below. 
PDGF  Binding and Competition Assays 
Highly purified PDGF-AB free of contaminating PDGF-AA or PDGF-BB 
was kindly provided by E. Raines and R. Ross (Department of Pathology, 
University of Washington) and was prepared as previously reported (Raines 
and Ross, 1982;  Seifert et al., 1989).  Highly purified recombinant PDGF- 
AA and  PDGF-BB  were  produced  from  yeast as  previously described 
(Bowen-Pope et al., 1989;  Seifert et al.,  1989).  These recombinant mole- 
cules were kindly provided by M. Murray and J. Forstrom (ZymoGenetics, 
Seattle, Washington). Radioiodination of the three PDGF forms, saturation 
binding of t25I-PDGF  to the cells, and competition assays were performed 
as previously described (Bowen-Pope et al.,  1989;  Seifert et al.,  1989). 
C2 ceils used for the assays were passaged into gelatin-coated, 24-well 
trays (well diameter =  16 nun) at a density of 5  x  104 cells/well and main- 
tained for  1-2  d  in proliferation medium until  •70%  confuent.  About 
16-20 h before assaying for PDGF binding, medium was changed to MEM 
containing 2 % FCS and antibiotics. This was done in order to reduce the 
amount of PDGF in the medium, which could bind to the PDGF receptors 
before the binding assay. C2 cells maintained in low serum differentiate ear- 
lier than cells in proliferation medium (detailed in Results); however, at the 
time of the binding assays over 98 % of the cells were not differentiated, and 
no myotubes were observed. For binding measurements, cultures were ex- 
posed at 4°C for 3 h to increasing amounts of ~25I-PDGF in binding buffer 
(Ham's medium F-12 buffered at pH 7.4  with 25  mM HEPES and sup- 
plemented with 0.25% BSA). Cultures were then rinsed with cold binding 
buffer,  and cell-bound 125I-PDGF was solubilized with  1%  Triton X-100 
containing 0.1% BSA and measured with a gamma counter. Nonspecific 
binding of PDGF, determined by preincubating ceils with an excess of unla- 
beled PDGF  (100  ng/ml),  was  subtracted to  determine the amount  of 
specifically bound label. Cell numbers were determined on wells that were 
treated as those for binding measurements. Cells were trypsinized and then 
counted, using an electronic particle counter. All measurements were done 
on triplicate wells. For competition binding, the cells were rinsed once with 
cold binding buffer and then incubated in 1 mi of binding buffer containing 
increasing amounts of  unlabeled PDGF-AA or PDGF-BB, followed by incu- 
bation with binding buffer containing 2  ng/ml  125I-PDGF-BB. Cells in- 
cubated with 2 ng/ml 125I-PDGF-BB only were used to determine control 
binding. Measurement of nonspecific binding and further analysis were as 
described for binding assays. 
~H-thymidine Incorporation 
To  assay the effect of PDGF on proliferation, cells were passaged into 
gelatin-coated, 24-well trays and plated, unless noted otherwise, at a density 
of 103-2.5  x  103 per well. Cells were maintained for 1 d in proliferation 
medium and then received a medium consisting of 2 % FCS plus antibiotics 
in MEM (2% FCS medium). Control wells received no further additives, 
whereas experimental wells received either PDGF-AA at 20 ng/ml, PDGF- 
AB at 5 ng/ml, or PDGF-BB at 20 ng/mi. To ensure ample supply of PDGE 
the medium and additives were replaced every 24 h. At daily intervals (be- 
fore the next medium change), cells were pulsed for 2  h  with  1 ~C/ml 
[3H]thymidine (3H-TdR; New England Nuclear, Boston, MA specific ac- 
tivity 6.7 Ci/mmole). At the end of the labeling period, cells were rinsed 
3x  with ice-cold MEM. This was followed by the addition of 1 ml of 5% 
ice-cold TCA,  in which the cells were maintained overnight at 4°C. Cells 
were then rinsed 2 x  with ice-cold 5 % TCA and dissolved in 0.5 ml of 0.5 N 
NaOH at 37°C. Plates were then subjected to vigorous rotating for 15-30 
rain to ensure complete detachment of cells, and the NaOH suspensions 
were transferred into scintillation vials. Radioactivity was measured using 
10 mi of ScintiVerse II (Fisher Scientific Co., Pittsburgh, PA). All measure- 
ments were made on triplicate wells. 
Detection of Terminally Differentiated Myoblasts 
Cells were cultured on gelatin-coated, 35-ram dishes, employing prolifera- 
tion medium, and then exposed to 2% FCS medium with or without PDGE 
as described above for 3H-TdR incorporation. Cultures were initiated at a 
density of 5-10  x  103 ceils per dish. Terminally differentiated cells were 
detected employing indirect immunofluorescence as previously described 
(Yablonka-Reuveni  and Nameroff,  1987;  Yablonka-Reuveni  et al.,  1987) 
and using the mAb MF20 which is specific for sarcomeric myosin. This an- 
tibody, which was originally prepared by Bader et al. (1982) and discussed 
in further publications (Zadeh et al., 1986; Saad et al., 1987), was obtained 
from the Developmental Studies Hybridoma Bank (maintained by a con- 
tract  from  NICHD  (NOI-HD-6-2915).  Growth medium  of hybridoma- 
producing MF20, the source of the antibody, was diluted 1:5 in 0.05 M Tris, 
0.9% NaC1,  1% normal goat serum, pH 7.4.  The secondary antibody was 
fluorescein-labeled goat anti-mouse IgG (Organon Teknika-Cappel, Mal- 
vern, PA) and was diluted to 1:50. After the antibody reaction, nuclei were 
stained with ethidium bromide and counted, using fluorescence microscopy 
to determine total cell numbers (including cells that fused into myotubes) 
and the proportion of terminally differentiated cells (including cells that 
fused into myotubes). Nuclei were labeled by exposing cultures for 5 min 
to two to three drops of ethidium bromide (2/~g/ml). Cultures were then 
rinsed extensively with 0.05 M Tris, 0.9% NaCI, 0.05%  Tween 20, pH 7.4, 
and received a final rinse with 0.05 M Tris, pH 7.4. Cultures were mounted 
with 90%  glycerol containing antifading agent (Yablonka-Reuveni  et al., 
1987) and observed with a Zeiss photomicroscope equipped for epifluores- 
cence. The bright red fluorescence of the nuclei could be visualized alone 
using the rhodamine filters or simultaneously with the antibody stain, em- 
ploying the fluorescein filters. Ten random fields per 35-mm dish were ana- 
lyzed, using duplicate dishes. 
Results 
C2 Myoblasts Express Different Numbers of  Binding 
Sites for the Three PDGF Isoforms 
Using  125I-PDGE we  determined  the  saturation  binding 
curves for the three different PDGF dimers, as shown in Fig. 
1. The saturation binding of PDGF-AA is  12  ×  l0  3 bound 
molecules per cell, that of PDGF-AB is 6.5  ×  10  3 bound 
molecules per  cell,  and  that of PDGF-BB is  165  x  103 
bound molecules per cell. Although high-affinity binding of 
all three dimers is detected, the number of PDGF-BB bind- 
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ing sites is, thus, many fold greater than that of the PDGF- 
AA or PDGF-AB binding sites. 
According  to  the  PDGF  receptor  model  proposed  by 
Seifert et al. (1989), PDGF-BB can bind to all three receptor 
types, whereas PDGF-AA can only bind to one receptor type 
(aa).  This  model  predicts  that  the  portion  of PDGF-BB 
binding to oltx and ctB receptors can be eliminated by incuba- 
tion with PDGF-AA to occupy the ct-subunits.  This allows 
us to use a competition binding protocol to test whether most 
of the PDGF receptors consist of/5/3 dimers, as implied by 
the results of the saturation binding. The results of such com- 
petition assays (Fig. 2) indicate that PDGF-AA competes for 
<20%  of the '25I-PDGF-BB binding sites and confirm that 
most of the  PDGF  receptors present  on  C2  cells  are /3/3 
receptors. 
PDGF-AA, PDGF-AB, and PDGF-BB Differentially 
Affect the Proliferation of C2 Myoblasts 
Mitogens contained in proliferation medium could obscure 
the specific effects of PDGF isoforms on myoblast prolifera- 
tion. Therefore, to analyze such effects, we maintained the 
cells in 2 % FCS medium to reduce the mitogens contributed 
by the basal medium. Incorporation of 3H-TdR after 24 h in 
this medium is reduced by about three- to fourfold and is fur- 
ther reduced by five- to sixfold by 48 h compared to cultures 
grown in proliferation medium (data not shown). Fusion into 
myotubes  occurs  in  cultures  maintained  in  the  2%  FCS 
medium earlier than in cultures maintained in proliferation 
medium,  even though  cells  in  2%  FCS  medium  are less 
crowded (Fig.  3,  a  and c).  However, differentiation of C2 
cells in the 2 % FCS  is cell density dependent and can be 
delayed by reducing  cell  density.  Therefore,  to  minimize 
differentiation  while  studying proliferation,  cultures  were 
initiated with low cell density as described under Materials 
and Methods,  unless otherwise noted. 
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Figure 1. Saturation binding of PDGF-AA, PDGF-AB, and PDGF- 
BB to C2 myoblasts. Cells were cultured in proliferation medium. 
24 h before the PDGF binding assay, the medium was replaced with 
MEM supplemented  with 2 % FCS to reduce  exogenous PDGE 
The plotted values represent the average specific binding to tripli- 
cate wells, and standard error was <10%. Cell numbers were deter- 
mined on parallel  triplicate  wells. 
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Figure 2.  Competition  binding  of PDGF-AA  and PDGF-BB for 
125I-PDGF-BB binding. After  initial  culturing  in  proliferation 
medium, cells were shifted to MEM supplemented with 2% FCS 
for 20 h. Cells were then incubated with increasing amounts of un- 
labeled PDGF-AA or PDGF-BB, followed by an incubation with 
2 ng/ml t25I-PDGF-BB. Controls were incubated with I25I-PDGF- 
BB alone. Plotted values represent specific binding as a percent of 
control.  Standard error was <10% for triplicate  wells. 
Yablonka-Reuveni et al. PDGF Effect during Myogenesis  1625 Figure 3.  Effect of serum and PDGF-BB on proliferation and fusion of C2 cells. Cells were cultured at 5  x  103 cells per 35-mm dish 
in proliferation medium. After 24 h, medium was replaced with fresh proliferation medium (a and b), 2% FCS medium (c and d), and 
0.25 mg/ml BSA medium (e and f). Only cultures b, d, andfreceived 20 ng/ml PDGF-BB. Medium, without or with PDGF, was replaced 
every 24 h thereafter.  Representative phase contrast micrographs  of live cultures were taken 96 h after initial culturing. Bar, 30 t~m. 
A summary of the effect of PDGF isoforms on 3H-TdR in- 
corporation is shown in Fig.  4.  In these experiments, cul- 
tures were initiated  with standard  cell density  (2.5  x  1@ 
cells per well), and the three PDGF isoforms were added at the 
time that cultures were exposed to the 2 % FCS. During the 
first day in 2%  FCS,  no differences in 3H-TdR incorpora- 
tion were observed in the proliferation of control cells or 
ceils that received PDGE However, during consecutive days 
in culture, the effect of PDGF-BB on cell proliferation be- 
came clear:  proliferation increased by over twofold on the 
second day of culture and by almost fivefold on the third day, 
compared to control cultures.  PDGF-AB had a small effect 
on cell proliferation and enhanced proliferation by 1.2- and 
1.5-fold  on  the  second  day  and  the  third  day  of culture, 
respectively. No effect of PDGF-AA on the level of prolifera- 
tion could be documented under these conditions. 
We could not document any significant effect of PDGF-BB 
on  3H-TdR  incorporation  when  added  to  C2  cells  main- 
tained in 20%  FCS (for morphological appearance of cells 
maintained in 20% FCS without or with PDGF-BB, see Fig. 
3, a and b). However, the effect of PDGF-BB on the prolifera- 
tion of C2 cells was not limited to cells maintained in 2 % 
FCS. A very dramatic response to this isoform was observed 
when C2  cells were maintained in  MEM  containing  only 
0.25 mg/ml BSA (Fig.  3, e and f).  Under these conditions, 
PDGF-BB  increased  the  cell  number  and  resulted  in  a 
3.5-4.5-fold  increase  in  3H-TdR incorporation  in  cultures 
maintained in BSA plus  PDGF-BB,  compared to cultures 
maintained in BSA alone (data not shown). Most of the cells 
in cultures lacking PDGF were bipolar (presumably, differ- 
entiated cells) or fused into small, multinucleated myotubes. 
Cultures  that  received PDGF-AA morphologically resem- 
bled cultures lacking PDGE Cultures that received PDGF- 
AB were intermediate in cell number and morphology (data 
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Figure 4.  Effect of the different isoforms of PDGF on 3H-TdR in- 
corporation. Cells were cultured at 2.5  x  103 cells/16-mm  well in 
proliferation medium for 24 h, followed by an exposure to 2% FCS 
in MEM for various lengths of time in the absence or presence of 
the different  PDGF isoforms.  PDGF-AA, PDGF-AB,  and PDGF- 
BB were added at 20, 5, and 20 ng/ml, respectively.  The 2 % FCS 
medium with or without PDGF was replaced every 24 h. 2 h before 
cell harvesting,  the cultures were exposed  to 3H-TdR at 1 #C/ml, 
and the extent of 3H-TdR incorporation into TCA precipitable ma- 
terial was determined. Plotted values represent the average of  tripli- 
cate wells.  Standard error was <5 %. 
not shown). For further studies, we used 2 % FCS medium 
and not BSA medium since many cells detached (presumably 
died) in the BSA medium,  making it unsuitable for longer 
term studies of proliferation and differentiation. 
The Manifestation of PDGF-BB Effect on Proliferation 
Is Cell Density Dependent 
In the experiments described in Fig. 4, the effect of PDGF- 
BB on cell proliferation was not observed until the second 
day in 2 % FCS. This could mean that the 2 % FCS medium 
contains enough PDGF or other mitogens to support the ini- 
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Figure 5.  Effect of PDGF-BB on proliferation of crowded C2 myo- 
blasts.  Cells  were  cultured  at  7.5  x  103  ceUs/16-mm  well  in 
proliferation  medium and  further treated  as described  in Fig.  2. 
Standard  error was <5 %. 
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Figure  6.  Effect of the  three  PDGF  isoforms on proliferation  of 
sparse C2 myoblasts. Cells were cultured at  103 cells/16-mm welt 
in proliferation medium and further treated as described in Fig. 2. 
Standard error was <5 %. 
tial cell proliferation,  but that when cells increase in num- 
bers,  they deplete  the endogenous mitogen(s),  and only at 
this stage would the effect of exogenous PDGF be detected. 
To test this possibility,  we examined 3H-TdR  incorporation 
in response to PDGF in cultures initiated with high and low 
cell densities.  As shown in Fig. 5, when starting cell densi- 
ties were higher than those described for Fig.  4,  the effect 
of PDGF-BB was already apparent after 36-48 h in 2 % FCS. 
By contrast,  the effect of the added PDGF-BB was delayed 
even further  (to day 4)  in experiments  where the cultures 
were initiated with fewer cells (Fig. 6). This supports the no- 
tion that 2 % FCS can sustain proliferation of sparse cells but 
that PDGF becomes limiting when cells reach higher densi- 
ties and deplete endogenous PDGF or other mitogens. 
Table L Frequency of  Myosin-positive  Cells in C2 Cultures 
Treated with PDGF 
48 h in 2%  FCS  72 h in 2%  FCS 
Nuclei in  Nuclei in 
PDGF  Total  myosin  +  % Differ-  Total  myosin  +  % Differ- 
added  nuclei  cells  entiation  nuclei  cells  entiation 
Experiment  1 
None  812  65  8.0  906  278  30.6 
AA  720  55  7.6  872  292  33.4 
AB  889  70  7.8  983  269  27.3 
BB  949  29  3.0  1231  126  10.2 
Experiment 2 
None  560  27  4.8  601  115  19.1 
AA  504  31  6.1  559  109  19.4 
AB  607  24  3.9  640  138  21.5 
BB  653  9  1.3  954  65  6.8 
Cells were fixed at indicated time points and identification  of differentiated 
cells was done immunohistochemically, using an antibody against sarcomeric 
myosin. Nuclei within myosin-positive cells (and multinucleated myotubes) 
and myosin-negative cells were visualized using ethidium bromide. Nuclear 
counts were made on duplicate 35-mm dishes, screening 10 random fields per 
dish. 
Yablonka-Reuveni et al. PDGF Effect during Myogenesis  1627 The Frequency of  Differentiated Myoblasts Is Reduced 
in the Presence of  PDGF-BB 
Various  studies have indicated that mammalian myoblasts 
differentiate in response to reducing the serum concentration 
in the growth medium (i.e., Yaffe,  1973;  Yaffe and Saxel, 
1977; Clegg et al., 1987; Fig. 3, this study). Our preliminary 
studies indicated that C2 cultures maintained in 2 % FCS in 
the presence of PDGF-BB exhibit fewer myotubes than in the 
absence of the factor (Fig. 3, c and d). To further investigate 
the effect of PDGF on C2 cells, we analyzed the frequency 
of terminally  differentiated  cells  in  control  and  PDGF- 
treated cultures maintained in 2%  FCS medium.  Cultures 
were initiated in proliferation medium then shifted to 2% 
FCS medium with or without PDGF as for 3H-TdR incor- 
poration assays.  Differentiated cells were detected with an 
antibody against sarcomeric myosin (MF20). Total cell num- 
bers, the number of differentiated mononucleated cells, and 
the number of cells fused into multinucleated fibers were de- 
termined by counting nuclei.  A  summary of this  study is 
shown in Table I. In all cases, PDGF-BB increased the total 
number of nuclei and decreased the  number of nuclei in 
differentiated cells. 
Discussion 
Our studies with the C2 myogenic line derived from adult 
mouse skeletal muscle demonstrate that these myoblasts ex- 
press receptors for PDGF and that PDGF exerts a mitogenic 
effect on these cells. Of the three known PDGF dimers, the 
BB isoform has the greatest number of binding sites on the 
C2 myoblasts and is the most potent in promoting 3H-TdR 
incorporation and in reducing the frequency of terminally 
differentiated myoblasts. Whereas PDGF-AA can bind to the 
cells, the number of binding sites is much lower than that 
of PDGF-BB and no mitogenic effect can be demonstrated. 
PDGF-AB binds to the C2 cells at a level similar to that of 
PDGF-AA and exerts a very slight mitogenic effect on the 
cells.  According to the  model proposed by  Seifert et al. 
(1989), PDGF-AA can only bind to the ctc~ receptor, PDGF- 
AB can bind to the c~ct and the c~/3 receptors, and PDGF-BB 
can bind to all three receptor combinations: oto~, ~/3, and/3/3. 
The saturation binding experiments indicate that the C2 cells 
express much higher levels of ~3- than a-receptor subunits. 
This is supported by the competition experiment (Fig. 2) which 
demonstrates that the ot-subunit accounts for <20 % of total 
receptor subunits. Other adult cell types also express many 
more/3- than ot-subunits  and respond much better to PDGF- 
BB than to PDGF-AA (e.g., see Seifert et al., 1989). Whether 
this difference in response results from quantitative differ- 
ences in signalling through the different receptor proteins or 
merely reflects quantitative differences in level of receptor 
subunit expression is not yet clear. 
The saturation binding experiments demonstrate that C2 
cells maintained in 2% FCS for 16-20 h express receptors 
to PDGF-BB. However, the response to PDGF-BB, as mea- 
sured by 3H-TdR incorporation, is delayed beyond 24 h  in 
cultures initiated at low cell densities. This delay in response 
may reflect the presence of enough mitogens in 2 % FCS to 
support the initial cell proliferation but that proliferation be- 
comes dependent on exogenous PDGF when these mitogens 
have been depleted by more crowded cells. In contrast to the 
stimulation  of proliferation,  the  number  of differentiated 
myoblasts is reduced in the presence of PDGF-BB. Little or 
no differentiation occurs during the first 24 h, even in the ab- 
sence of PDGE As cells become more crowded, mitogens 
become limiting, and increasing numbers of myoblasts dif- 
ferentiate and exit the cell cycle in the absence of PDGE 
In the presence of PDGF, fewer cells differentiate, and more 
cells  are  available  for the  next round of cell division.  If 
PDGF operates by suppressing differentiation rather than by 
promoting proliferation, then another mitogen needs to be 
present in sufficient amounts in the mitogen-depleted cul- 
tures in order to promote proliferation. It is possible that 
PDGF-BB functions both as a mitogen and as a suppressor 
of cell differentiation, and the effect of PDGF becomes pro- 
nounced through the combined effects of decreased frequency 
of withdrawal from the cell cycle and increased number of 
undifferentiated cells available for the next round of cell di- 
vision. 
The binding of PDGF to skeletal muscle cells and the re- 
sponse of these cells to PDGF has been studied previously, 
but only briefly. Linkhart et al.  (1982) mentioned that the 
mouse myoblast cell line MM14, which, like the C2 cell line, 
was derived from adult muscle, did not respond to PDGF 
(primarily AB isoform). More recent studies on these MM14 
myoblasts indicate that they do not bind PDGF-BB (Bowen- 
Pope and Olwin, unpublished results). Bischoff (1986), using 
isolated intact muscle fibers containing satellite cells in their 
native position under the basement membrane, concluded 
that the addition of PDGF did not activate the proliferation 
of quiescent satellite cells. This study did not investigate the 
effects of PDGF following the initial activation of satellite 
cells, and employed PDGF-AB, which is also a poor mitogen 
for C2 cells. By contrast, studies of cultured avian myoblasts 
have indicated a potential role for PDGF during certain stages 
of  myogenesis.  Venkatasubramanian  and  Solursh  (1984) 
showed that PDGF (the AB type) can induce a migratory re- 
sponse in a myogenic cell population from avian limb buds. 
We have previously demonstrated a  significant binding of 
PDGF-AB to myogenic cultures from adult chicken skele- 
tal muscle but not to such cultures from 10 day embryos 
(Yablonka-Reuveni et al.,  1988,  1990). Thus, it is possible 
that myoblasts from different developmental and physiologi- 
cal stages respond differently to PDGE Another intriguing 
possibility is that PDGF, which is a chemoattractant for a va- 
riety of cells (Sepp~i et al.,  1982; Grotendorst et al.,  1982; 
reviewed in Ross et al.,  1986), as well as for cells in avian 
limb buds  (Venkatasubramanian and Solursh,  1984),  may 
affect the migration of satellite cells.  Such migration from 
regions distal to the injury would be an additional source for 
myoblasts during regeneration (Mauro, 1979; Schultz et al., 
1988; Watt et al.,  1987). 
In summary, the experiments presented in this study using 
a rodent satellite cell-derived cell line provide the first direct 
evidence that PDGF can regulate myoblast proliferation and 
differentiation in vitro. It is thus possible that PDGF has a 
role in increasing the number of myoblasts during skeletal 
muscle regeneration by stimulating proliferation and/or in- 
hibiting differentiation. 
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